Ancient and modern anticonvulsants act synergistically in a KCNQ potassium channel binding pocket
Rían W Manville, Geoffrey W Abbott, Rían W Manville, Geoffrey W Abbott
Abstract
Epilepsy has been treated for centuries with herbal remedies, including leaves of the African shrub Mallotus oppositifolius, yet the underlying molecular mechanisms have remained unclear. Voltage-gated potassium channel isoforms KCNQ2-5, predominantly KCNQ2/3 heteromers, underlie the neuronal M-current, which suppresses neuronal excitability, protecting against seizures. Here, in silico docking, mutagenesis and cellular electrophysiology reveal that two components of M. oppositifolius leaf extract, mallotoxin (MTX) and isovaleric acid (IVA), act synergistically to open neuronal KCNQs, including KCNQ2/3 channels. Correspondingly, MTX and IVA combine to suppress pentylene tetrazole-induced tonic seizures in mice, whereas individually they are ineffective. Co-administering MTX and IVA with the modern, synthetic anticonvulsant retigabine creates a further synergy that voltage independently locks KCNQ2/3 open. Leveraging this synergy, which harnesses ancient and modern medicines to exploit differential KCNQ isoform preferences, presents an approach to developing safe yet effective anticonvulsants.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
- White HS. Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia. 2003;44:2–8. doi: 10.1046/j.1528-1157.44.s7.10.x.
- Kamatenesi-Mugisha M, Oryem-Origa H. Traditional herbal remedies used in the management of sexual impotence and erectile dysfunction in western Uganda. Afr. Health Sci. 2005;5:40–49.
- Spinella M. Herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy Behav. 2001;2:524–532. doi: 10.1006/ebeh.2001.0281.
- Kukuia KK, Ameyaw EO, Mante PK, Adongo DW, Woode E. Screening of central effects of the leaves of Mallotus oppositifolius (Geiseler) Mull. Arg. in mice. Pharmacologia. 2012;3:683–692. doi: 10.5567/pharmacologia.2012.683.692.
- Kukuia KK, Ameyaw EO, Woode E, Mante PK, Adongo DW. Enhancement of inhibitory neurotransmission and inhibition of excitatory mechanisms underlie the anticonvulsant effects of Mallotus oppositifolius. J. Pharm. Bioallied Sci. 2016;8:253–261. doi: 10.4103/0975-7406.183226.
- Gangwar M, Goel RK, Nath G. Mallotus philippinensis Muell. Arg (Euphorbiaceae): ethnopharmacology and phytochemistry review. Biomed. Res. Int. 2014;2014:213973. doi: 10.1155/2014/213973.
- Abbott, G. W. Biology of the KCNQ1 potassium channel. N. J. Sci.2014, 237431 (2014).
- Wang HS, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science. 1998;282:1890–1893. doi: 10.1126/science.282.5395.1890.
- Selyanko AA, et al. Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell. J. Neurosci. 1999;19:7742–7756. doi: 10.1523/JNEUROSCI.19-18-07742.1999.
- Singh NA, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 1998;18:25–29. doi: 10.1038/ng0198-25.
- Charlier C, et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 1998;18:53–55. doi: 10.1038/ng0198-53.
- Biervert C, et al. A potassium channel mutation in neonatal human epilepsy. Science. 1998;279:403–406. doi: 10.1126/science.279.5349.403.
- Rostock A, et al. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res. 1996;23:211–223. doi: 10.1016/0920-1211(95)00101-8.
- Tober C, Rostock A, Rundfeldt C, Bartsch R. D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. Eur. J. Pharmacol. 1996;303:163–169. doi: 10.1016/0014-2999(96)00073-8.
- Rundfeldt C. The new anticonvulsant retigabine (D-23129) acts as an opener of K+channels in neuronal cells. Eur. J. Pharmacol. 1997;336:243–249. doi: 10.1016/S0014-2999(97)01249-1.
- Main MJ, et al. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol. Pharmacol. 2000;58:253–262. doi: 10.1124/mol.58.2.253.
- Tatulian L, Delmas P, Abogadie FC, Brown DA. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J. Neurosci. 2001;21:5535–5545. doi: 10.1523/JNEUROSCI.21-15-05535.2001.
- Tatulian L, Brown DA. Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells. J. Physiol. 2003;549:57–63. doi: 10.1113/jphysiol.2003.039842.
- Garin Shkolnik T, et al. Blue-gray mucocutaneous discoloration: a new adverse effect of ezogabine. JAMA Dermatol. 2014;150:984–989. doi: 10.1001/jamadermatol.2013.8895.
- Mathias SV, Abou-Khalil BW. Ezogabine skin discoloration is reversible after discontinuation. Epilepsy Behav. Case Rep. 2017;7:61–63. doi: 10.1016/j.ebcr.2017.01.001.
- Schroder RL, et al. KCNQ4 channel activation by BMS-204352 and retigabine. Neuropharmacology. 2001;40:888–898. doi: 10.1016/S0028-3908(01)00029-6.
- Blackburn-Munro G, Dalby-Brown W, Mirza NR, Mikkelsen JD, Blackburn-Munro RE. Retigabine: chemical synthesis to clinical application. CNS Drug. Rev. 2005;11:1–20. doi: 10.1111/j.1527-3458.2005.tb00033.x.
- Dupuis DS, et al. Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352. Eur. J. Pharmacol. 2002;437:129–137. doi: 10.1016/S0014-2999(02)01287-6.
- Korsgaard MP, et al. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. J. Pharmacol. Exp. Ther. 2005;314:282–292. doi: 10.1124/jpet.105.083923.
- Wickenden AD, Yu W, Zou A, Jegla T, Wagoner PK. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol. Pharmacol. 2000;58:591–600. doi: 10.1124/mol.58.3.591.
- Igwe KK, Madubuike AJ, Otuokere IE, Amaku FJ, Chika I. GC-MS analysis for structural identification and bioactive compounds in methanolic leaf extract of Mallotus oppositifolius. Int. J. Sci. Res. Manag. 2016;4:4123–4129.
- Oliver, B. E. P. Medicinal Plants in Nigeria (Nigerian College of Arts, Science and Technology, Lagos, Nigeria, 1960).
- Manville RW, Papanikolaou M, Abbott GW. Direct neurotransmitter activation of voltage-gated potassium channels. Nat. Commun. 2018;9:1847. doi: 10.1038/s41467-018-04266-w.
- Kim RY, et al. Atomic basis for therapeutic activation of neuronal potassium channels. Nat. Commun. 2015;6:8116. doi: 10.1038/ncomms9116.
- Matschke V, et al. The natural plant product Rottlerin activates Kv7.1/KCNE1 channels. Cell. Physiol. Biochem. 2016;40:1549–1558. doi: 10.1159/000453205.
- Zaika O, Hernandez CC, Bal M, Tolstykh GP, Shapiro MS. Determinants within the turret and pore-loop domains of KCNQ3 K+channels governing functional activity. Biophys. J. 2008;95:5121–5137. doi: 10.1529/biophysj.108.137604.
- Schenzer A, et al. Molecular determinants of KCNQ (Kv7) K+channel sensitivity to the anticonvulsant retigabine. J. Neurosci. 2005;25:5051–5060. doi: 10.1523/JNEUROSCI.0128-05.2005.
- Lange W, et al. Refinement of the binding site and mode of action of the anticonvulsant Retigabine on KCNQ K+ channels. Mol. Pharmacol. 2009;75:272–280. doi: 10.1124/mol.108.052282.
- Turner, W. A New Herball, Parts II and III (Steven Mierdman, London, UK, 1562, 1568).
- Grieve, M. A Modern Herbal: The Medicinal, Culinary, Cosmetic and Economic Properties, Cultivation and Folk-lore of Herbs, Grasses, Fungi, Shrubs, & Trees with All Their Modern Scientific Uses (1971).
- Bruno JJ, Ellis JJ. Herbal use among US elderly: 2002 National Health Interview Survey. Ann. Pharmacother. 2005;39:643–648. doi: 10.1345/aph.1E460.
- Zakharov SI, Morrow JP, Liu G, Yang L, Marx SO. Activation of the BK (SLO1) potassium channel by mallotoxin. J. Biol. Chem. 2005;280:30882–30887. doi: 10.1074/jbc.M505302200.
- Zeng H, et al. Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator. J. Pharmacol. Exp. Ther. 2006;319:957–962. doi: 10.1124/jpet.106.110593.
- Gschwendt M, et al. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 1994;199:93–98. doi: 10.1006/bbrc.1994.1199.
- Burkhill, H. M. The Useful Plants of West Tropical Africa (Royal Botanic Gardens, Kew, London, UK, 1994).
- Hasan MM, et al. Analgesic and anti-inflammatory activities of leaf extract of Mallotus repandus (Willd.) Muell. Arg. Biomed. Res. Int. 2014;2014:539807.
- Patel RK, Patel VR, Patel MG. Development and validation of a RP-HPLC method for the simultaneous determination of Embelin, Rottlerin and Ellagic acid in Vidangadi churna. J. Pharm. Anal. 2012;2:366–371. doi: 10.1016/j.jpha.2012.03.001.
- Donath F, et al. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry. 2000;33:47–53. doi: 10.1055/s-2000-7972.
- Dorn M. Valerian versus oxazepam: efficacy and tolerability in nonorganic and nonpsychiatric insomniacs: a randomized, double-blind, clinical comparative study [in German] Forsch. Komplement. Klass. Nat. 2000;7:79–84.
- Stevinson C, Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep. Med. 2000;1:91–99. doi: 10.1016/S1389-9457(99)00015-5.
- Eadie MJ. Could valerian have been the first anticonvulsant? Epilepsia. 2004;45:1338–1343. doi: 10.1111/j.0013-9580.2004.27904.x.
- Bialer M, et al. Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V) Epilepsy Res. 2001;43:11–58. doi: 10.1016/S0920-1211(00)00171-6.
- Frost G, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun. 2014;5:3611. doi: 10.1038/ncomms4611.
- Sun J, MacKinnon R. Cryo-EM structure of a KCNQ1/CaM complex reveals insights into congenital long QT syndrome. Cell. 2017;169:1042–1050 e1049. doi: 10.1016/j.cell.2017.05.019.
- van Gunsteren, W. F. Biomolecular Simulation: the GROMOS96 Manual and User Guide (Vdf Hochschulverlag ETHZ, 1996).
- Johansson MU, Zoete V, Michielin O, Guex N. Defining and searching for structural motifs using DeepView/Swiss-PdbViewer. BMC Bioinformatics. 2012;13:173. doi: 10.1186/1471-2105-13-173.
- Grosdidier A, Zoete V, Michielin O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 2011;39:W270–W277. doi: 10.1093/nar/gkr366.
- Grosdidier A, Zoete V, Michielin O. Fast docking using the CHARMM force field with EADock DSS. J. Comput. Chem. 2011;32:2149–2159. doi: 10.1002/jcc.21797.
- Abbott GW, et al. KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability. Sci. Signal. 2014;7:ra22. doi: 10.1126/scisignal.2005025.
Source: PubMed